Company: IXHL
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001213900-25-013783
Chunk: 2

Company: Incannex Healthcare Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
  
     6,824 
  
    Foreign exchange losses 
     (326) 
     (5) 
     (331) 
     (6)
  
    Interest income 
     28  
     20  
     57  
     90 
  
    Interest expense 
     (171) 
     -  
     (171) 
     - 
  
    Change in fair value of convertible rights 
     (179) 
     -  
     (179) 
     - 
  
    Change in fair value of warrant liabilities 
     (103) 
     -  
     (103) 
     - 
  
    ELOC commitment fee 
     (1,095) 
     -  
     (1,095) 
     - 
  
    Total other income, net 
     (890) 
     2,742  
     (55) 
     6,908 
  
    Loss before income tax expense 
     (5,894) 
     (5,241) 
     (11,313) 
     (5,968)
  
    Income tax expense 
     -  
     -  
     -  
     - 
  
    Net loss 
    $(5,894) 
    $(5,241) 
    $(11,313) 
    $(5,968)
  
    Other comprehensive income/(loss): 

     - 
  
    Currency translation adjustment, net of tax 
     (414) 
     927  
     (75) 
     418 
  
    Total comprehensive loss 
    $(6,308) 
    $(4,314) 
    $(11,388) 
    $(5,550)
  
    Net loss per share: Basic and diluted 
    $(0.33) 
    $(0.33) 
    $(0.65) 
    $(0.38)
  
    Weighted average number of shares outstanding, basic and diluted 
     17,624,422  
     15,873,113  
     17,563,200  
     15,873,113 

The accompanying notes are an integral part of
these condensed consolidated financial statements. 

2

INCANNEX HEALTHCARE INC.

Condensed Consolidated Statements of Stockholders’